z-logo
open-access-imgOpen Access
Voriconazole and cobicistat-boosted antiretroviral salvage regimen co-administration to treat invasive aspergillosis in an HIV-infected patient
Author(s) -
Juan Ambrosioni,
S Coll,
Christian Manzardo,
David Nicolás,
Fernando Agüero,
José L. Blanco,
Montserrat Tuset,
Merçè Brunet,
José M. Gatell,
José M. Miró
Publication year - 2016
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkv449
Subject(s) - voriconazole , medicine , aspergillosis , regimen , cobicistat , salvage therapy , human immunodeficiency virus (hiv) , virology , antiretroviral therapy , surgery , chemotherapy , immunology , viral load , antifungal , dermatology
Juan Ambrosioni1*†, Sandra Coll2†, Christian Manzardo1, David Nicolás1, Fernando Agüero1, José Luis Blanco1, Montse Tuset3, Mercé Brunet4, José M. Gatell1 and José M. Miró1 Infectious Diseases Service, Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain; School of Medicine, University of Barcelona, Barcelona, Spain; Pharmacy Service, Hospital ClinicIDIBAPS, University of Barcelona, Barcelona, Spain; Toxicology and Pharmacology Service, Hospital Clinic-IDIBAPS, University of Barcelona, Barcelona, Spain

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom